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There are conflicting results from studies on whether the ventilation (V) scintigraphy can be 
safely omitted or replaced by a chest x-ray. These studies were based on planar ventilation 
perfusion (V/Q) scintigraphy. We evaluated the value of the V single photon emission 
computed tomography (SPECT) on the final conclusion drawn from a V/Q SPECT and the 
possible role of the chest x-ray as a surrogate for the V SPECT. 
Methods  
Raw data of V/Q SPECT images and chest x-ray acquired within 48 hours over 18 months 
period were retrieved, reprocessed and reviewed in batches. The V SPECT, Q SPECT and chest 
x-ray were reviewed separately and in combination. Data on the presence and character of 
defects and chest x-ray abnormalities were recorded. The V/Q SPECT images were interpreted 
using the criteria in the EANM guideline and the Q SPECT and chest x-ray images were 
interpreted using the PISAPED criteria. Agreement between the diagnosis on the V/Q SPECT 
review and the Q SPECT and chest x-ray review was analysed. 
Results 
21.1% of the patients were classified as ‘PE present’ on the V/Q SPECT review whereas 48.9% 
were classified as ‘PE present’ on the Q SPECT and chest x-ray review. Only 5.4% of defects 
seen on V SPECT had matched chest x-ray lung field opacity. 
Conclusion 
Our study showed that the omission of a V SPECT led to a high rate of false positive diagnoses 
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1.0 RESEARCH PROTOCOL 
This research protocol was submitted to and approved by the Faculty of Health Sciences, 
University of Cape Town before the commencement of the study. 
Research topic – The conclusions drawn from ventilation/perfusion single photon emission 
computed tomography (SPECT) compared to lung perfusion SPECT and a chest x-ray (CXR) 
in patients with suspected pulmonary thromboembolism. 
1.1 Background  
Acute pulmonary thromboembolism (PE) is the most serious form of venous 
thromboembolism. The incidence rate of non- cancer associated venous thromboembolism in 
the UK in a recent study was 107 per 100,000 person years, pulmonary thromboembolism 
accounting for 45.9% (1). Symptoms, signs and laboratory findings are not sufficiently specific 
for diagnosis of acute PE which is based on imaging and clinical course. Accurate diagnosis is 
very important as the main therapeutic option of management of acute PE, long term 
anticoagulation, is associated with increased risk of bleeding. 
Pulmonary angiography is the gold standard in acute PE imaging (2, 3). This is however not 
widely available largely because the procedure is technically demanding, involves cannulation 
of the pulmonary vessels for the injection of contrast media and is associated with risks of 
vascular cannulation(4). Ventilation/perfusion (V/Q) scintigraphy and computed tomography 
pulmonary angiography (CTPA) are the widely used alternatives to pulmonary angiography in 
acute PE imaging. Planar V/Q scintigraphy and CTPA have been shown to have similar 
diagnostic accuracy. V/Q SPECT has a higher diagnostic accuracy compared to planar V/Q 
scintigraphy (5-7).   
V/Q scintigraphy is a non-invasive and relatively simple procedure. Absent or reduced 




scintigraphy was added to differentiate other causes of perfusion abnormalities (8, 9). The more 
demanding for the radiographer and the patient is the ventilation component. In addition, 
following the low diagnostic yield of planar V/Q scintigraphy and the large number of non-
diagnostic scans in the PIOPED I study (2), there have been studies showing that planar 
perfusion only scintigraphy performs as well as planar V/Q scintigraphy with lower rate of 
non-diagnostic scans (3, 10-12).  
Miniati et al in their review based on the result of the PISAPED study suggested that Q 
scintigraphy combined with a chest x-ray should be sufficient for diagnosis and a V scan should 
only be obtained in select cases (10). Their recommendation is based on planar images and 
there is limited literature on the additional value of V SPECT or chest x-ray on Q SPECT. A 
literature search on 28 February 2016 using the key words ‘ventilation perfusion SPECT’ of 
PubMed, web of science and Scopus databases revealed no publication comparing Q SPECT 
with V/Q SPECT and one publication that compared V/Q SPECT to Q SPECT/CT (13). This 
project seeks to evaluate the extent to which the final conclusion on a V/Q SPECT is influenced 
by the V SPECT and if the chest x-ray can act as a substitute for a V SPECT. 
1.2 Literature review 
Acute pulmonary thromboembolism (PE) is the most serious form of venous thromboembolism 
(VTE) (14, 15). The incidence of acute PE in the United Kingdom is about 50 per 100,000 
person years (1). A slightly higher annual incidence of 69 per 100,000 persons was reported in 
the United States (16). The crude mortality rate in patients diagnosed with pulmonary 
embolism was 17.4% from presentation up to 3 months in the international cooperative 
pulmonary embolism study(17). 
Clinical presentation of acute PE ranges from completely asymptomatic to sudden death (18). 




are non-specific and include dyspnoea, tachypnoea, syncope, haemoptysis, tachycardia and 
hypotension (18, 19). Because of the nonspecific presentation, evaluating a patient for 
pulmonary embolism is based on a high index of suspicion and high pre-test probability using 
validated clinical prediction rules such as the Wells score (20, 21) where scores are assigned 
to seven significant variables as summarized in table 1. 
Table 1: Wells score 
Clinical Characteristic Score 
Previous pulmonary embolism or deep vein thrombosis + 1.5 
Heart rate >100 beats per minute + 1.5 
Recent surgery or immobilization (within the last 30 d) + 1.5 
Clinical signs of deep vein thrombosis + 3 
Alternative diagnosis less likely than pulmonary embolism + 3 
Haemoptysis + 1 
Cancer (treated within the last 6 months) + 1 
  





Measurement of D-dimer, a fibrin degradation product with elevated plasma concentration 
following fibrinolysis, is an ancillary investigation in acute pulmonary thromboembolism. A 




probability(22). A positive D-dimer however has low specificity as it is elevated in several 
other conditions including the elderly, pregnant women, malignancy, inflammation and 
thromboembolism other than PE (23).  
Electrocardiography and echocardiography may show features of right ventricular strain in 
pulmonary thromboembolism but are not sufficiently sensitive or specific for PE(24). 
Treatment of acute PE involves anticoagulation for a long duration (14, 25). Thrombolytic 
therapy is beneficial in cases associated with hypotension(25) and right ventricular dysfunction 
(26). Both anticoagulation for a long period and thrombolysis are associated with significant 
increased risk of major haemorrhage and stroke (25, 26). It is therefore important to establish 
a diagnosis of acute PE in order to avoid unnecessary treatment. Imaging and clinical course 
are the accepted standard for diagnosis (2, 3, 14). The imaging modalities include  pulmonary 
angiography, CTPA and V/Q scintigraphy (27). Other less commonly used imaging methods 
are transthoracic echocardiography for assessing the consequences of massive acute PE on the 
right ventricle and visualization of emboli in the right ventricle(5), transthoracic 
ultrasonography of the lungs(28) and venous ultrasonography for deep vein thrombosis(29). 
Pulmonary angiography is the ‘gold standard’ against which the other imaging techniques are 
measured (2, 30).The use of pulmonary angiography is limited because of the risks of vascular 
catheterization and technical demand of the procedure (4, 31). 
The main event in acute PE is obstruction in the pulmonary arterial bed with decreased or 
absent perfusion to the lung tissue distal to the obstruction. There is transient associated 
hypoventilation in areas of obstruction due to hypocapnia and humoral factors released from 
platelets involved in the thromboembolic event. Hypoperfusion leads to decreased surfactant 
formation and subsequent atelectasis (32). Lung parenchymal infarction distal to the 




thromboembolism (involving more than 30% of the pulmonary vascular bed) results in 
increased pulmonary vascular bed resistance, pulmonary hypertension and eventually right 
heart failure which is often the cause of death in acute PE (14, 33).  
Radionuclide imaging of acute PE started with planar perfusion scintigraphy (34, 35). Wagner 
et al in 1964 described the development and initial evaluation of a new radioisotope scanning 
procedure for the diagnosis of massive pulmonary embolism in man using macroaggregated 
albumin labelled with 131I or 51Cr(34). Soon after, Moser et al in an experimental study  
investigated the reliability and specificity of pulmonary angiography and perfusion photo 
scanning under experimental conditions They showed a substantial degree of agreement in 
detecting pulmonary thromboemboli (35). 
Lung perfusion follows the segmental anatomy of the lungs. Occlusion of the segmental/ sub 
segmental pulmonary arteries leads to wedge shaped segmental/ sub segmental perfusion defect 
with apex located centrally and the base on the pleural surface. More peripherally placed 
arterial occlusions may give crescentic defects. The diagnosis of acute PE on perfusion 
scintigraphy is based on segmental/ sub segmental wedge shaped absent or reduced perfusion 
to part(s) of the lungs. The presence of perfusion defect is not specific for acute PE as it can be 
seen in other lung disorders including infection, tumours, obstructive airway disease, asthma 
and congenital pulmonary vascular anomalies (8). To improve specificity, V scintigraphy was 
combined with Q scintigraphy shortly after the introduction of Q scintigraphy (8). The basis of 
the combination is that acute PE will usually cause a perfusion defect with a normal ventilation 
or a perfusion defect which is worse than abnormal ventilation in the same area of the lung 
(ventilation perfusion mismatch). Conversely, in lung parenchymal disorders, perfusion and 
ventilation are affected to the same extent (matched) or ventilation abnormality is worse than 




therefore made when there is ventilation-perfusion mismatch that corresponds to the pulmonary 
vascular anatomy (2, 36). 
Currently, planar or SPECT V/Q scintigraphy and CTPA are the most widely used imaging 
modalities for diagnosis of pulmonary embolism. CTPA became the imaging modality of 
choice in most centres because of rapidity, easy accessibility and better diagnostic abilities 
compared to V/Q scintigraphy with detection of alternative diagnosis (30, 37, 38). However, 
the above conclusions on CTPA were based on comparison of CTPA with planar V/Q 
scintigraphy. Advances in ventilation radiopharmaceuticals and the introduction of V/Q 
SPECT imaging have shown that V/Q SPECT has a similar or better diagnostic yield than 
CTPA with the advantage of lower radiation dose (6, 7, 38-40). CTPA is also associated with 
over diagnosis of clinically insignificant pulmonary embolism (37). 
Lung ventilation scintigraphy has been the more challenging part of the V/Q scintigraphy. 
Getting a good V scan requires patient cooperation and use of an appropriate ventilation 
radiopharmaceutical. The ideal ventilation radiopharmaceutical is 81mKr(41) which is a gas and 
reflects true ventilation. However, the short physical half-life of the 81Ru – 81mKr generator, 
limited availability and high cost limit its use (36, 41). The closest alternative to 81mKr is 
aerosolized technetium graphite particles called Technegas (which are about 300times bigger 
than a Krypton atom). The relatively small particle size (0.005 – 0.2µm) produced by the 
Technegas generator makes it better than the liquid radioaerosols (41, 42). When Technegas 
generator is not available, liquid radioaerosols such as 99mTc-DTPA, 99mTc-sulfur colloid and 
99mTc-PYP are generated using nebulization chambers. They are larger particles than 
Technegas and are less suited for ventilation scintigraphy (43).   
A few studies have shown that in certain situations, a chest x-ray performs as well as planar V 




scan versus V/Q scan using planar images. They analysed 389 patients with at least one 
segmental perfusion defect on perfusion scan. There was an overall agreement of 88% between 
the X/Q scan and V/Q scan for classifying perfusion defect as matched or mismatched. In a 
subset of their patients with COPD, the chest x-ray performed poorly in identifying matched 
defects. They concluded that in patients without COPD, the chest x-ray can reliably replace 
ventilation scintigraphy in categorizing perfusion defects as matched or mismatched (44).  
Similarly, Grimm and colleagues assessed the utility of the ventilation scan in planar V/Q scan 
in a retrospective study of planar V/Q scan and chest x-ray reports. They studied 500 
consecutive patients, 65 of whom had perfusion defects. Seventy point eight percent (70.8%) 
of the 65 with perfusion defect had no corresponding ventilation defect. The percentage of 
those with no ventilation defect increased from 70.8% to 95.7% when patients with respiratory 
disease and abnormal chest x-ray were excluded. In this subset of patients with unmatched 
perfusion defect, there was statistically significant association between a normal ventilation 
and a normal chest x-ray. The authors concluded that there may be a sub set of patients (young 
patients with clear chest radiograph and no respiratory disease) for whom the V scan may be 
excluded(45).  
Using different interpretation criteria, various authors reported that the planar Q scan alone has 
similar diagnostic validity compared to the planar V/Q scan. Stein et al evaluated the value of 
planar V/Q scans versus Q perfusion scans alone in acute PE. 98 patients were randomly 
selected from the PIOPED I studies. The characteristics of these patients were not statistically 
different from the rest of the 1,389 patients in PIOPED I who had planar V/Q scans. The V/Q 
scans and Q scans of these 98 patients were independently read using the PIOPED criteria. 
They found that the diagnostic validity of a high probability or low probability planar 




perfusion scan. They also found that the number of those who had intermediate (indeterminate) 
probability scans is more, though not statistically significant, in patients who had only Q 
perfusion scans. They therefore suggested that in such patients, a planar V/Q scan may give a 
more definitive probability (12). 
The PISAPED investigators evaluated 890 patients with suspected pulmonary embolism using 
planar Q only scintigraphy. Scans were interpreted with the PISAPED criteria where emphasis 
was laid on the conformation of the defect to the pulmonary vascular anatomy. Taking 
pulmonary angiography as the gold standard, they found a sensitivity of 92% and specificity 
of 87% for planar perfusion only scintigraphy. They concluded that accurate diagnosis is 
possible with Q scans alone, without ventilation imaging (3, 10). In the PISAPED study, the 
chest x-ray was not used as a surrogate for the ventilation scan, scintigraphic diagnosis was 
based purely on the shape of the perfusion defect (10) . 
A recent attempt to replicate the work of the PISAPED investigators by Van Es and co-workers 
compared planar Q scintigraphy and chest x-ray to CTPA. They found a sensitivity of 60% and 
specificity of 86% for the Q perfusion and chest x-ray. The positive predictive value for ‘PE 
present’ was 71% and negative predictive value for ‘PE absent’ was 83%. They concluded that 
a diagnostic strategy of planar Q scintigraphy and chest x-ray using the PISAPED criteria is 
less safe compared to CTPA (46). In a letter commenting on this study, Miniati identified the 
mode of interpretation, presumed commencement of anticoagulant/thrombolytic therapy (after 
the CTPA and before planar perfusion scanning) and sample size as probable factors 
responsible for the low sensitivity in the study(47).  
Similarly, a recent study by Watanabe et al using planar images found a lower sensitivity using 
the PISAPED criteria for Q only scintigraphy (clinical outcome at 24 weeks was gold standard). 




V scintigraphy leads to significant improvement in sensitivity (9). Most of the studies (some 
of which are summarized above) on the value of the ventilation or chest x-ray in V/Q 
scintigraphy were done with planar ventilation perfusion images. 
Over the years, V/Q scanning has evolved from planar scintigraphy to V/Q SPECT 
scintigraphy. Several studies have shown the superiority of V/Q SPECT over planar V/Q in 
sensitivity and specificity (48-51). Gutte et al showed a sensitivity and specificity of 100% and 
87% for V/Q SPECT compared to 64% and 72% for planar V/Q. The gold standard was a 
combination of CTPA, V/Q scintigraphy and clinical follow up (51). Similarly, Bajc et al found 
that V/Q SPECT showed 53% more mismatch points compared to planar V/Q in patients with 
acute PTE (49). In another study, 102 patients had planar and SPECT V/Q. Sixty two percent 
(62%) of the scans were non-diagnostic on planar V/Q compared to 4.9% on SPECT V/Q. In 
this last study, modified PIOPED criteria was used for interpretation of planar images and the 
EANMMI guideline was used for the SPECT images (52). 
In an experimental study by Bajc and co-workers, sixteen anesthetized pigs were artificially 
embolized with thallium labelled latex material. Imaging of the thallium distribution served as 
the ‘gold standard’. In a subset of the pigs who had cylindrical embolic material (seven pigs), 
the ventilation images were not analysable due to ventilation artefacts. However, the planar 
perfusion images showed a sensitivity and specificity of 71% and 91% compared to 100% 
sensitivity and specificity for perfusion SPECT images. In the remaining nine pigs, flat 3-tailed 
embolic latex material was used. The sensitivity and specificity of planar V/Q was 64% and 
79% respectively compared to 91% and 87% for SPECT ventilation/perfusion scintigraphy 
(48).   The better diagnostic yield from SPECT is due to its better spatial resolution and ability 




Even though there is clear superiority of SPECT lung scintigraphy over planar images, the 
studies assessing the utility of the ventilation images are mostly based on planar lung 
scintigraphy. A literature search on 28 February 2016 using the key words ‘ventilation 
perfusion SPECT’ of PubMed, web of science and Scopus databases revealed no publication 
comparing perfusion SPECT with V/Q SPECT and one publication that compared V/Q SPECT 
to Q SPECT/CT (13). Palmowski and co-workers compared the performance of Q SPECT/CT 
(low dose unenhanced CT) to V/Q SPECT. Using V/Q SPECT as the gold standard, they found 
a sensitivity of 95.8%, specificity of 82.6% and false positive of 17.3% for perfusion 
SPECT/CT. They concluded that V SPECT should be a fixed part of the V/Q SPECT/CT in 
order to improve specificity and lower the false positive rate. The study was retrospective with 
no independent gold standard and no documentation of co morbidities especially COPD (13).  
The research proposed aims to evaluate the value of the V SPECT on the final conclusion 
drawn from a V/Q SPECT. It will also evaluate the role of the chest x-ray as a surrogate for the 
V SPECT.  
1.3 Research questions 
1. Is the identification of an abnormality the same when perfusion SPECT is reviewed 
without and with a ventilation SPECT?  
2. Is the identification of an abnormality the same when ventilation SPECT is reviewed 
without and with a perfusion SPECT?  
3. Is the final diagnosis on a perfusion only SPECT the same as that on a ventilation 
perfusion SPECT?  
a. Is there a particular subset of patient where the final diagnosis is the same?  




4. Is the final diagnosis on a perfusion SPECT + chest X-ray the same as that on a 
ventilation perfusion SPECT?  
a. Is there a particular subset of patient where the final diagnosis is the same?  
b. Is there a particular subset of patients where the final diagnosis is different?  
5. How often do we have a normal ventilation SPECT when the chest X-ray is normal? 
6. How often are defects on ventilation SPECT seen as abnormalities on chest X-ray?  
1.4 Methods 
1.4.1 Patients: 
The name, hospital folder number of each patient who had a V/Q SPECT study in the 
Division/Department of Nuclear Medicine at Groote Schuur Hospital between June 2014 and 
December 2015 will be retrieved from the Division’s clinical database (reference number: 
R006/2012) with a copy of the request form and the tick sheet completed by the referring 
physician at the time the study was requested.  The raw data of each V/Q SPECT study will be 
retrieved from the Division’s electronic image archive (GSH Hermes archive), matched with 
the demographic information. The Hospital’s PACS will be searched for chest X-rays of these 
patients.  Patients who had a V/Q SPECT for suspected pulmonary embolism and a chest X-
ray within 48 hours will be included in this study.  It is expected that 200 scans will be available 
for the study. 
All the scans were done for diagnostic purposes as part of the care of each patient in accordance 
with the guidelines of the European Association of Nuclear Medicine on V/Q scintigraphy (36) 
for the diagnosis of acute pulmonary thromboembolism in patients with a clinical suspicion of 




1.4.2 Image acquisition: 
The V/Q SPECT images were acquired using Technegas and Tc-99m macro aggregated 
albumin (IBA molecular) and either a Siemens ecam signature series dual head gamma camera 
or a Symbia hybrid SPECT-CT system (Siemens Medical Solutions). The V SPECT 
acquisition was started when a count rate of 2 – 3 kilocounts/second was achieved, with 128 
projections (64 per camera head) at 10 seconds per projection. The Q SPECT images, 128 
projections at 5 seconds per projection, were acquired immediately after the V SPECT with the 
patient in the same position.  The count rate for the Q SPECT was 10 – 15 kilocounts/second. 
Frontal and/or lateral chest x-rays were acquired using the GSH radiology department protocol.   
1.4.3 Data collection: 
Raw SPECT data will be reprocessed and viewed on a Siemens physicians’ work station. 
Reconstruction will be done using OSEM 2D iterative reconstruction with 4 subsets and 8 
iterations. The observer will review separately the V SPECT, Q SPECT, V SPECT with Q 
SPECT, Q SPECT with chest x-ray, V SPECT with chest x-ray of each patient. Data will be 
recorded on the relevant data sheets (appendix V, page 67). 




Study Batch 1 Batch 2 Batch 3 Batch 4 Batch 5 Batch 6 
Ventilation  1 – 33 34- 67 68- 101 102 – 135 136-169 170-200 
Perfusion  34 - 67 68- 101 102 - 135 136 – 169 170-200 1 – 33 
Ventilation with 
perfusion 
68 - 101 102 - 135  136-169 170-200 1-33 34- 67 
CXR 102-135 136-169 170-200 1-33 34-67 68-101 
Perfusion with 
CXR 
136-169 170-200 1-33 34-67 68-101 102-135 
Ventilation with 
CXR 
170-200 1-33 34-67 68-101 102-135 136-169 
 
For example, during the review of batch 1, ventilation scans of patients 1 – 33, perfusion of 34 
-67, ventilation/ perfusion of 68 – 101, chest x-ray of 102 – 135, perfusion scan and chest x-
ray of 136 – 169 and ventilation scan and chest x-ray of 170 – 200 will be reviewed. 
For all SPECT reviews, a pictorial representation of the lung segments in sagittal, coronal and 
transverse sections will be used to localize involved segments on the ventilation or perfusion 
scan (appendix IV, page 65).     
For the V SPECT, data on the character (absent or reduced), number, location, size and shape 
of defect(s) will be recorded. The same set of features will be recorded for the Q SPECT.  
Similarly, for the V/Q SPECT, the character, number, location, size and shape of the defects 
will be recorded. In addition, the association of the defects – matched or unmatched and relative 




For the chest x-ray, the presence and location of pulmonary oligaemia, central vessel 
enlargement with abrupt tapering, peripheral consolidation abutting the pleura, atelectasis, 
small pleural effusion, elevated hemidiaphragm, right ventricular enlargement and lung field 
opacities will be recorded. In addition, the presence of hyperinflation, pulmonary oedema, hilar 
nodes, airway compression and massive pleural effusion will be recorded.  
The location of abnormalities/opacities on the frontal chest x-ray will be marked on a pictorial 
representation of a normal chest x-ray during the chest x-ray data collection. The chest x-ray 
will be reviewed with a radiologist. 
Associated chest x-ray opacity will be recorded for the Q SPECT with chest x-ray and V 
SPECT with chest x-ray series.  
The folder number, age, gender and presence of comorbidity will be retrieved from the request 
form and the clinical information tick sheet and recorded in a separate data sheet. 
1.4.4 Interpretation criteria: 
The ventilation/ perfusion SPECT will be interpreted using the EANM guideline as detailed 
below: 
Ventilation/ perfusion SPECT 
EANM guideline  
1. PE present 
a.  VQ mismatch of at least one segment or two sub segments that conforms 
to the pulmonary vascular anatomy 
2. PE absent 




b. Matched perfusion defects of any size, shape or number in the absence of 
mismatch in any other part of the lung 
c. Reverse mismatch defects of any size, shape or number in the absence of 
mismatch in any other part of the lung 
d. Mismatch that does not have a lobar, segmental or sub segmental pattern 
3. Non-diagnostic 
a. Multiple VQ abnormalities that do not have patterns described in 1 and 2 
There are no parallel criteria for the interpretation of the perfusion SPECT with chest x-ray, so 
two different interpretation criteria will be used:  
A. The PISAPED criteria; and 
B. A modified version of the EANM guideline with ventilation SPECT replaced by chest 
x-ray. 
These are detailed below:   
A. The PISAPED criteria 
PE absent 1. Normal – no perfusion defect of any kind 
 
2. Near normal – perfusion defects equal or smaller in size and 
shape to the following CXR abnormalities: cardiomegaly; 
enlarged aorta, hila and mediastinum; elevated diaphragm; 
blunting of the costophrenic angle; pleural thickening; 




3. Abnormal (PE negative) – single or multiple defects other 
than wedge shaped with or without matching CXR 
abnormalities. 
PE present 1. Abnormal (PE positive) – single or multiple wedge-shaped 
perfusion defects with or without matching CXR 
abnormalities. 
 
B. Modified EANM guideline with ventilation SPECT replaced by chest X-ray 
1. PE present 
a. Perfusion defect of at least one segment or two sub segments that 
conform to the pulmonary vascular anatomy with no associated 
CXR abnormality 
2. PE absent 
a. Normal perfusion pattern 
b. Perfusion/CXR matched defects of any size, shape or number in the 
absence of mismatch in any other part of the lung 
c. Perfusion/CXR reverse mismatch defects of any size, shape or 
number in the absence of mismatch in any other part of the lung 
d. Mismatch that does not have a lobar, segmental or sub segmental 
pattern 
3. Non-diagnostic 






1.4.8 Data analysis: 
Data will be entered into a data base and analysed for predictive value of a normal/abnormal 
chest x-ray for a normal/abnormal V SPECT, agreement between the final conclusion on the 
V/Q SPECT and Q SPECT/chest x-ray, relationship between patient’s age/comorbidities and 
V SPECT, influence of addition of V SPECT on the number of perfusion defects detected and 
vice versa. 
1.5 Study limitations: 
 A single observer will be involved in interpreting the nuclear medicine scans 
1.6 Ethical issues: 
The study involves re-evaluation of raw images previously acquired and stored in the Nuclear 
Medicine database already registered by the Human Research Ethics Committee of the Faculty 
of Health Sciences with reference number: R006/2012. These studies were performed 
according to guidelines of the European Association of Nuclear Medicine on ventilation 
perfusion scintigraphy (36) for the diagnosis of acute pulmonary thromboemboli in patients 
with clinical suspicion of acute pulmonary thromboemboli. 
Patients’ details used in the study will only be available to individuals involved in the study 
and will be properly kept. No patients’ detail will be used in the final report. Patients’ 
confidentiality will be maintained throughout the study in compliance with the Helsinki 
declaration(54).   
1.7 Funding: 
Images to be analysed have already being acquired and stored as part of establishing the 




done. There will therefore be no further cost to the patient or hospital for this study. The cost 
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There are conflicting results from studies on whether the ventilation (V) scintigraphy can be 
safely omitted or replaced by a chest x-ray. These studies were based on planar ventilation 
perfusion (V/Q) scintigraphy. We evaluated the value of the V single photon emission 
computed tomography (SPECT) on the final conclusion drawn from a V/Q SPECT and the 
possible role of the chest x-ray as a surrogate for the V SPECT. 
Methods  
Raw data of V/Q SPECT images and chest x-ray acquired within 48 hours over 18 months 
period were retrieved, reprocessed and reviewed in batches. The V SPECT, Q SPECT and chest 
x-ray were reviewed separately and in combination. Data on the presence and character of 
defects and chest x-ray abnormalities were recorded. The V/Q SPECT images were interpreted 
using the criteria in the EANM guideline and the Q SPECT and chest x-ray images were 
interpreted using the PISAPED criteria. Agreement between the diagnosis on the V/Q SPECT 
review and the Q SPECT and chest x-ray review was analysed. 
Results 
21.1% of the patients were classified as ‘PE present’ on the V/Q SPECT review whereas 48.9% 
were classified as ‘PE present’ on the Q SPECT and chest x-ray review. Only 5.4% of defects 
seen on V SPECT had matched chest x-ray lung field opacity. 
Conclusion 
Our study showed that the omission of a V SPECT led to a high rate of false positive diagnoses 









2.3 MAIN MANUSCRIPT 
Research topic – The conclusions drawn from ventilation/perfusion single photon 
emission computed tomography (SPECT) compared to lung perfusion SPECT and a 
chest x-ray in patients with suspected pulmonary thromboembolism. 
Introduction  
Acute pulmonary thromboembolism (PE) is the most serious form of venous 
thromboembolism(1, 2). The clinical presentation of acute PE is non-specific and ranges from 
completely asymptomatic to sudden death(3, 4). Accurate diagnosis of acute PE is important 
as the main options of management, thrombolysis and long-term anticoagulation, are associated 
with significant risk of major haemorrhage and stroke(5, 6). The gold standard for diagnosis is 
a combination of imaging findings and clinical course on long term follow up(1, 7, 8). 
The main imaging modalities in acute PE include pulmonary angiography, computed 
tomography pulmonary angiography (CTPA) and ventilation perfusion scintigraphy (V/Q 
scan)(9). Pulmonary angiography is accepted as the gold standard in acute PE imaging(7, 10) 
but is not widely used because of the technical demand and associated complications(11, 12).  
V/Q scan can be done either as a planar study or single photon computed emission tomography 
(SPECT) study. Since the advent of SPECT, Ventilation-Perfusion SPECT (V/Q SPECT) has 
been shown to be superior in sensitivity and specificity compared to planar V/Q scan(13-16). 
Compared to CTPA, V/Q SPECT has similar or better diagnostic yield with added advantage 
of lower radiation dose(17-20). A recent service evaluation study by Parekh and colleagues 
reinforced the utility of the V/Q SPECT in acute PE imaging especially in terms of its high 
negative predictive value(21). 
The diagnosis of acute PE on V/Q scan is based on the presence of perfusion defect that 




or ventilation defect of smaller magnitude compared to the perfusion defect (ventilation-
perfusion mismatch)(7, 22). The PISAPED investigators however reported that accurate 
diagnosis is possible with a perfusion scan alone without ventilation imaging(8, 23). While 
some investigators have also reported that the ventilation scintigraphy can be reliably replaced 
by chest x-ray(24, 25), others could not replicate the diagnostic results of the PISAPED 
investigators(26, 27). The idea that that the ventilation scan can be omitted or replaced by a 
chest x-ray is very attractive, given that it is the more demanding part of the study. A high-
quality ventilation scan requires a cooperative patient who has the stamina to take enough deep 
inspirations to move aerosol to the periphery of the lung. It is also the more expensive 
component of a V/Q scan, particularly when one of the best radiopharmaceuticals, 81mKr or 
Technegas, is used.  
The original PISAPED study and attempts to replicate it were all based on planar V/Q scan. 
With the established superiority of the V/Q SPECT over planar V/Q scan(14-16), we evaluated 
the value of the ventilation SPECT on the final conclusion drawn from a V/Q SPECT and the 
possible role of the chest x-ray as a surrogate for the ventilation SPECT. 
Methods  
Patients: 
The name and hospital folder number of each patient who had a V/Q SPECT performed for the 
diagnosis of suspected acute PE in the Division of Nuclear Medicine at Groote Schuur Hospital 
between 1 June 2014 and 31 December 2015 were retrieved from the Division’s clinical 
database (reference number: R006/2012) with a copy of the request form and the tick sheet 
completed by the referring physician at the time the study was requested.  The raw data of each 
V/Q SPECT were retrieved from the Division’s electronic image archive (GSH Hermes 




of symptoms and within 48 hours was required as part of departmental protocol to triage 
patients with grossly abnormal chest x-ray and normal renal function to CTPA. The Hospital’s 
PACS was searched for chest X-rays of these patients.  Patients who had a V/Q SPECT and a 
chest X-ray within 48 hours were included in the study.   
All the scans were done for diagnostic purposes as part of the care of each patient. Scans were 
acquired in accordance with the guidelines of the European Association of Nuclear Medicine 
on ventilation perfusion scintigraphy (22) for the diagnosis of acute pulmonary 
thromboembolism. 
Image acquisition: 
The V/Q SPECT images were acquired using Technegas generated from technigasplus 
(Cyclomedica Australia Pty Ltd) and Tc-99m macro aggregated albumin (Pulmocis, IBA 
molecular) and either a Siemens e.cam signature series dual head gamma camera or a Symbia 
TruePoint SPECT.CT system (Siemens Medical Solutions). The V SPECT acquisition was 
started when a count rate of 2 – 3 kilocounts/second was achieved, with 128 projections (64 
per camera head) at 10 seconds per projection. The Q SPECT images, 128 projections at 5 
seconds per projection, were acquired immediately after the V SPECT with the patient in the 
same position.  The count rate for the Q SPECT was 10 – 15 kilocounts/second. 
Posterior-anterior, with or without lateral, chest x-rays were acquired using the GSH radiology 
department protocol (Appendix 1).    
Data collection: 
For this analysis, raw SPECT data were reprocessed and viewed on a Siemens physicians’ work 
station (SyngoMI VA1OC, WinNT 5.1, Service pack 3). Reconstruction was done using 
OSEM 2D iterative reconstruction with 4 subsets and 8 iterations. The observer reviewed 




V SPECT with chest x-ray of each patient. Data were recorded on the relevant data sheets (see 
appendix 2). The studies were reviewed in batches with at least one week between batches.  
For example, during the review of batch 1, ventilation scans of patients 1 – 33, perfusion of 34 
-67, ventilation/ perfusion of 68 – 101, chest x-ray of 102 – 135, perfusion scan and chest x-
ray of 136 – 169 and ventilation scan and chest x-ray of 170 – 200 were reviewed. 
For all SPECT reviews, a pictorial representation of the lung segments in sagittal, coronal and 
transverse sections was used to localize involved segments on the ventilation or perfusion scan 
(appendix 3). For the V SPECT, data on the character (absent or reduced), number, location, 
size and shape of each defect were recorded. The same set of parameters were recorded for the 
Q SPECT. Similarly, for the V/Q SPECT, the character, number, location, size and shape of 
the defects were recorded. In addition, the association of the defects – matched or unmatched 
and relative sizes were recorded. 
For the chest x-ray, the presence and location of pulmonary oligaemia, central vessel 
enlargement with abrupt tapering, peripheral consolidation abutting the pleura, atelectasis, 
small pleural effusion, elevated hemidiaphragm, right ventricular enlargement and lung field 
opacities were recorded. In addition, the presence of hyperinflation, pulmonary oedema, hilar 
nodes, airway compression and massive pleural effusion were also recorded. Chest x-ray 
opacities associated with a ventilation or perfusion defect were recorded for the Q SPECT with 
chest x-ray and V SPECT with chest x-ray series.  
The folder number, age, gender and presence of comorbidity were retrieved from the request 
form and the clinical information tick sheet and recorded in a separate data sheet. 
Interpretation criteria: 
The findings on the combined V/Q SPECT were interpreted using the criteria outlined in the 




The findings on a separate review of the Q SPECT with chest x-ray (without ventilation 
images) was interpreted using the PISAPED criteria as detailed in table 2.  
Data analysis: 
Data were entered into multiple Microsoft Excel worksheets and analysed using Microsoft 
Excel 2013 and Stata 13.0 (StataCorp. 2013. Stata: Release 13. Statistical Software. College 
Station, TX: StataCorp LP.).  
Data were analysed for agreement in identification of perfusion defects when the Q SPECT 
was reviewed alone and with the V SPECT. The agreement between the final conclusion on 
the V/Q SPECT and the Q SPECT and chest x-ray was also analysed. The relationship between 
the presence of a ventilation defect and lung field opacity on chest x-ray was analysed. 
Ethical approval: 
Study was duly approved by the Human Research Ethics Committee of the Faculty of Health 
Sciences, University of Cape Town. HREC REF: 508/2016. 
RESULTS 
A total of 307 patients had V/Q SPECT for the diagnosis of suspected pulmonary embolism in 
the 18 months period under review (1 June 2014 to 31 December 2015). A chest x-ray acquired 
within 48hours of the V/Q SPECT was available on the hospital PACS for 205 patients, 66.8% 
of total number of patients. Of these 205 patients, 6 had missing clinical information leaving a 
total of 199 patients. A further 19 patients were excluded due to the technical quality of the 
images (see below) and therefore the final analysis was done on 180 patients. 
The gender distribution of patients was 153 (85%) females and 27 (15%) males. The age range 




with caesarean section accounting for 48 (79%) of the surgeries and 16 had coexisting 
malignancy.    
 
Technical quality of images 
The 19 patients excluded had one or more poor quality images. On review of the ventilation 
SPECT images, 14 studies were of poor technical quality due to central deposition of most of 
the activity, low counts peripherally and excessive movement. Five of these studies were also 
of poor quality on review of the perfusion SPECT images due to marked inhomogeneity that 
made identification and localization of perfusion defects impossible. Another 5 studies were 
excluded on chest x-ray images review due to poor inspiration or under penetration. Hence, a 
total of 19 studies had poor quality and were excluded. 
Perfusion defects  
When the Q SPECT images were reviewed alone, a total of 285 perfusion defects were 
identified. When reviewed with the V SPECT, the number of perfusion defects dropped to 273. 
Of the 285 perfusion defects identified on Q SPECT only review and the 273 perfusion defects 
identified on the V/Q SPECT review, 230 perfusion defects were similar in both reviews in 
terms of location, size and shape. The remaining 55 defects on Q SPECT and 43 defects on 
V/Q SPECT differed. Hence, in terms of similarities in identification of perfusion defects, 81% 
of the perfusion defects identified on Q SPECT and 84% of perfusion defects identified on V/Q 
SPECT were the same. Table 3 is a summary of the perfusion defects and the number of patients 




A total of 109 out of 180 patients had one or more perfusion defects on Q SPECT review. This 
number dropped to 105 out of 180 patients when the Q SPECT was reviewed with the V 
SPECT. Table 4 is a summary of perfusion defect identification in patients. 
 
Ventilation defects 
When the V SPECT images were reviewed alone, one or more ventilation defects were 
identified in 67 patients. There was no ventilation defect in 113 patients. On review of the V/Q 
SPECT images, one or more ventilation defects were recorded in 71 patients and in 109 
patients, no defect was recorded. In 55 patients, one or more ventilation defects were seen in 
both reviews. Ventilation defects were recorded in 12 patients on only V SPECT review and 
in 16 patients on only V/Q SPECT review.  
The total number of ventilation defects recorded on the V SPECT review was 113 with a range 
of 1 to 8 and median of 1. On the V/Q SPECT review, the total number of ventilation defects 
was 125 with a range of 1 to 7 and median of 1.    
Diagnosis  
A total of 105 patients had one or more perfusion defects on the V/Q SPECT review. Nineteen 
of these 105 patients had non-wedge-shaped perfusion defects only and were classified as ‘PE 
absent’ according to the EANM criteria. Of the 86 that had one or more wedge shaped perfusion 
defects, 1 patient had only non-pleural based defects and therefore also classified as ‘PE 
absent’. Of the remaining 85 patients with one or more wedge shaped pleural based perfusion 
defects, 38 had matched ventilation defects or reverse mismatch leaving a total of 47 patients 
with one or more pleural based ventilation-perfusion mismatched defects (table 5). Using the 
EANM criteria, 38 of the 47 patients were classified as ‘PE present’ and 9 as ‘non-diagnostic’. 




patients with no perfusion defects, 133 patients (73.9%) were classified as ‘PE absent’, 38 
patients (21.1%) were classified as ‘PE present’ and 9 patients (5%) were classified as ‘non-
diagnostic’ (table 6). 
Using the PISAPED criteria, a total of 109 patients had one or more perfusion defects, 21 had 
only non-wedge-shaped defects and were therefore classified as ‘PE absent’. The remaining 88 
patients had one or more pleural based wedge-shaped perfusion defects (table 5).  Hence, 
including the 71 patients with no perfusion defects, 92 studies (51.1%) were classified as ‘PE 
absent’ and 88 studies (48.9%) were classified as ‘PE present’ (table 5). 
Table 6 is a cross tabulation of the agreement in diagnosis between the EANM criteria for 
interpretation of the V/Q SPECT and PISAPED criteria for the interpretation of the Q SPECT 
and chest x-ray. 
The final diagnosis using the EANM criteria for interpretation of the V/Q SPECT and 
PISAPED criteria for the Q SPECT and chest x-ray was the same in 119 patients (66.1%). The 
final diagnosis was different in 61 patients (33.9%).  
Forty-eight patients were classified as ‘PE absent’ on V/Q SPECT interpreted with EANM 
criteria but as ‘PE present’ on Q SPECT and chest x-ray interpreted with PISAPED criteria. In 
these 48 patients, the total number of defects seen on the Q SPECT only review was 100 with 
a range of 1 to 8 defects and a median of 1.5 defects. Each of the 48 patients had one or more 
pleural based wedge-shaped defect on the Q SPECT review. On the V/Q SPECT review, total 
number of perfusion defects in these 48 patients was 94 with a range of 0 to 7 defects and 
median of 1 – 6 patients had no perfusion defect, 19 had one perfusion defect each and 23 had 
two or more perfusion defects. Eighty of the 94 perfusion defects on V/Q SPECT review had 
matched/ reverse mismatched ventilation defects. The remaining 14 perfusion defects were 




of PE. Table 7 shows the differences in defect characterization on review of the V/Q SPECT 
and perfusion SPECT and chest x-ray in these 48 patients. 
The 9 patients classified as ‘non-diagnostic’ on V/Q SPECT interpreted with EANM had 2 
sub-segmental pleural based wedge-shaped perfusion defects each, one of which was 
mismatched and the other matched. Using the PISAPED criteria, 6 of these 9 patients were 
classified as ‘PE present’ on perfusion SPECT chest x-ray and these 6 had 1 to 3 sub-segmental 
wedge shaped pleural based perfusion defects. The remaining 3 patients classified as ‘PE 
absent’ on PISAPED criteria had 1 non-wedge sub-segmental perfusion defect each.  
Four patients were classified as ‘PE present’ on V/Q SPECT review using the EANM criteria 
but classified as ‘PE absent’ on perfusion SPECT chest x-ray review. These 4 patients had 2 or 
more wedge shaped pleural based mismatched defects on V/Q SPECT review. On the perfusion 
SPECT chest x-ray review, 3 of the patients had 1 non-wedged perfusion defects each and 1 
patient had no defect.  
Chest x-ray 
Eighty six percent of the patients had chest x-ray within 24 hours of the V/Q SPECT after the 
and after the onset of symptoms. The conclusion on review of the chest x-ray images was 
‘normal’ in 37 (21%) patients, ‘abnormal, likely PE’ in 13 (7%) patients, ‘abnormal, unlikely 
PE’ in 116 (64%) patients and ‘abnormal, consistent with COPD’ in 14 (8%) patients. 
When the ventilation SPECT was reviewed with chest x-ray, 111 ventilation defects were 






The diagnosis of pulmonary embolism on V/Q scintigraphy is based on the concept of 
ventilation-perfusion mismatch - the presence of a perfusion defect in an area of the lung with 
normal ventilation or a smaller ventilation. Other causes of lung perfusion defect such as 
infection, tumours, obstructive airway disease, asthma and congenital pulmonary vascular 
anomaly are associated with a similar or larger ventilation defect(28). The PISAPED 
investigators showed that accurate diagnosis is possible with planar perfusion scintigraphy and 
chest x-ray(8), a conclusion that couldn’t be replicated by others(26, 27).  These studies are 
based on planar images. Since SPECT images are more sensitive in the identification and 
characterisation of defects, we investigated whether using SPECT images will support the 
findings of the PISAPED investigators. We found that omission of the ventilation SPECT led 
to a high rate of false positive scans.  
In the identification and characterization of defects on V/Q scintigraphy, the intra and inter 
observer agreement is good, more so in experienced observers (29, 30). A similar trend was 
found in this study as over 80% of the perfusion defects were identified and characterized in 
the same way by a single observer who reviewed the V/Q SPECT and the Q SPECT at two 
different time points. There was a decrease in the number of perfusion defects and the number 
of patients with defects when the Q SPECT was reviewed with the V SPECT. This may be 
related to a combination of intra observer variability and the added confidence in excluding the 
presence of a perfusion defect when the Q SPECT was reviewed with the V SPECT. The 
agreement in the identification of ventilation defects when the V SPECT was reviewed alone 
or with the Q SPECT was similar. 
In this study, 21.1% of the patients were classified as ‘PE present’ on V/Q SPECT using the 
EANM criteria. This is in keeping with prevalence of 19% to 33% of positive scans among 
patients investigated for acute PE reported in previous papers(7, 19, 26, 31). Using the 




study were classified as ‘PE present’. This is slightly higher than the prevalence reported in the 
PISAPED study where it was 44.4%(8) and by Watanabe and colleagues where it was 
40.3%(27).  The higher prevalence in our study may be due to detection of more perfusion 
defects on SPECT compared to planar perfusion scintigraphy which was used in the PISAPED 
study and by Watanabe and colleagues.  
Forty-eight patients classified as ‘PE present’ when the Q SPECT and chest x-ray was 
interpreted with the PISAPED criteria were classified as ‘PE absent’ on V/Q SPECT 
interpreted with EANM criteria. This difference may be accounted for by differences in 
identification of perfusion defects on the 2 separate reviews of the perfusion images, the 
addition of the ventilation SPECT or the interpretation criteria. 
Of the 48 patients classified as ‘PE present’ on the Q SPECT chest x-ray (PISAPED) review 
but as ‘PE absent’ on V/Q SPECT (EANM) review, 6 can be attributed to differences in 
identification of perfusion defects as these 6 had no perfusion defect on V/Q SPECT review. 
The interpretation criteria also played a role as 5 of the 6 patients had only one sub-segmental 
defect each and were classified as ‘PE absent’ on the V/Q SPECT.  
In 19 of the 48 patients, the difference in diagnoses can be attributed to the interpretation 
criteria and the addition of the ventilation images. In these 19 patients, 10 had single sub-
segmental defects and will therefore be classified as ‘PE absent’ according to the EANM 
criteria but as ‘PE present’ according to the PISAPED criteria. Nine patients had 1 matched 
segmental perfusion defect each and hence in these 9 patients, the difference is due to the 
addition of the V SPECT. The difference in the remaining 23 of the 48 patients can be attributed 
to the addition of the ventilation SPECT as all perfusion defects that would have been classified 




Overall, the difference in conclusion in 32 (66.7%) of the 48 patients can be attributed to the 
addition of a ventilation scan, in 10 patients (20.8%) to the interpretation criteria and in 6 
patients (12.5%) to a combination of differences in interpretation criteria and perfusion defect 
identification in the two separate reviews.  
With the established sensitivity and specificity of the V/Q SPECT(17, 19), this study showed 
that the omission of a ventilation scan led to 32 more patients being classified as ‘PE present’. 
Using the EANM criteria as standard, of the 133 patients classified as ‘PE absent’, 32 patients 
had false positive scans – a false positive rate of 24%. These patients are at risk of being given 
unnecessary treatment with attendant adverse effects. 
As for the identification of ventilation defects on a chest x-ray, only 5.4% of the ventilation 
defects were seen as lung field opacity on chest x-ray. This is not unexpected because 
physiologic derangement precedes anatomic abnormality and ventilation scan is physiologic 
whereas the chest x-ray is anatomic. Even with more sensitive anatomic imaging modalities, a 
normal area may have an abnormality on ventilation scan as reported by Palmowski and 
colleagues who showed ventilation defects in anatomically normal areas of the lung on CT(32). 
To our knowledge, this is the first study comparing V/Q SPECT to perfusion SPECT and chest 
x-ray. Palmowski and colleagues compared V/Q SPECT to perfusion SPECT- CT scan. The 
rate of false positive finding attributable to the addition of the ventilation in their study was 
17.3%. We found a higher false positive rate of 24%. This difference may be due to differences 
in interpretation as the CT scan was used as a replacement for ventilation SPECT in their study 
while in our study, the chest x-ray findings were ancillary findings and not a replacement as 
outlined in the PISAPED study. 
There was a preponderance of females of child bearing age in our study population, 85% of 




is no consensus on the age adjusted male to female ratio in the incidence of pulmonary 
embolism with some studies showing a higher female preponderance and others a higher male 
preponderance(33-36). The incidence rate is however higher in females during child bearing 
years(33). The pattern of referral in our centre may be due to a higher index of suspicion in 
females in this age group and a lower threshold to investigate for acute PE. The significance of 
the higher female ratio on the findings in this study is uncertain.   
Limitations of this study include review of the V/Q SPECT images by a single observer, non-
availability of an independent gold standard and absence of long term follow up with clinical 
review of diagnosis of PE present/ absent. Other limitations include the retrospective nature of 
the study and use of chest x-ray images acquired within 48 hours. However, 86% of the patients 
had chest x-ray within 24hours of the V/Q SPECT 
Conclusion  
Our study showed that the omission of a ventilation SPECT and the use of PISAPED criteria 
in the diagnosis of acute PE on perfusion SPECT and chest x-ray led to a high rate of false 
positive diagnoses and that the ventilation SPECT cannot be replaced by a chest x-ray.  
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Table 1: EANM guideline for V/Q SPECT interpretation 
*A V/Q mismatch that conforms to the pulmonary vascular anatomy is defined as a wedge shaped, pleural based perfusion 








1. PE present a. V/Q mismatch of at least one segment or two sub 
segments that conform to the pulmonary vascular 
anatomy* 
2. PE absent a. Normal perfusion pattern 
b. Matched perfusion defects of any size, shape or 
number in the absence of mismatch in any other 
part of the lung 
c. Reverse mismatch defects of any size, shape or 
number in the absence of mismatch in any other 
part of the lung 
d. Mismatch that does not have a lobar, segmental 
or sub segmental pattern 
3. Non-diagnostic a. Multiple V/Q abnormalities that do not have 




Table 2: The PISAPED criteria for interpretation of V/Q SPECT and chest x-ray 
PE absent 1. Normal – no perfusion defect of any kind 
 
2. Near normal – perfusion defects equal or smaller in size 
and shape to the following CXR abnormalities: 
cardiomegaly; enlarged aorta, hila and mediastinum; 
elevated diaphragm; blunting of the costophrenic angle; 
pleural thickening; intrafissural collection of liquid 
3. Abnormal (PE negative) – single or multiple defects other 
than wedge shaped with or without matching CXR 
abnormalities. 
PE present 1. Abnormal (PE positive) – single or multiple wedge-shaped 





















































285 109 230 96* 55 36* 1 14 2 
V/Q 
SPECT 
273 105 230 43 26* 1 12 2 
*Numbers of patients with defects add up to greater than 109 on perfusion SPECT review because 23 patients had both similar and 

























Q SPECT 71 62 9 109 96 
V/Q 
SPECT 














1) Defects (number of patients) 273(105) 285(109) 
a) Non-wedge shaped only (patients) 23(19) 28(21) 
b) One or more wedge shaped (patients) 250(86) 257(88) 
i) Non-pleural based only (patients) 2(1) 0(0) 
ii) One or more pleural based 
(patients) 248(85) 257(88) 
(1) Matched/ reverse mismatched 
defects only (patients) 112(38)  
(2) One or more mismatched 







Table 6: Final diagnoses cross tabulation 
 
PISAPED 
EANM PE present PE absent Total 
PE present 34 4 38 
PE absent 48 85 133 
Non-diagnostic 6 3 9 







Table 7 – Defect characterization in patients classified as ‘PE absent’ on EANM criteria for 

































6 0 - - - 6 W    6 SS 5 
NW 0 S   1 
19 19 W    15 SS 10 MIS 6 25 W    22 SS 14 
NW 4 S   9 M    13 NW 3 S   11 
23 75 W    52 SS 37 MIS 8 69 W    61 SS 27 
NW 23 S   38 M    67 NW 8 S   42 
Q=perfusion, W=wedge shaped, NW=non-wedge shaped, MIS=mismatched, M=matched and reverse mismatched, SS=sub-













3.2 APPENDIX II: GSH Radiology Chest x-ray protocol 
GSH CHEST X-RAY PROTOCOL: PA CHEST X-RAY 
SID     180cm 
AREA COVERED    Lung fields, apices, costophrenic angles, heart 
SIZE AND ORIENTATION OF CASSETTE 35 X 43cm; Landscape but may be portrait depending on 
patient size. 
POSITIONING Patient facing the cassette/ detector with the chin extended 
and centred to the middle of the top of the cassette. Feet 
placed slightly apart so the patient can remain steady. 
 Clear the scapulae off the lung fields by rotating the 
shoulders forward and pressed downward to make contact 
with the cassette. This is achieved by placing the dorsal 
aspects of the hands behind and below the hips with the 
elbows brought forward or by allowing the arms to encircle 
the cassette. Expose on inspiration. 
CENTRING POINT Midsagittal plane at the level of T4/ inferior border of the 
scapula, perpendicular to the image receptor. 
COLLIMATION open to show the lung apices superiorly and the 
costophrenic angles inferiorly. Open to show the lung fields 
laterally. 






3.3 APPENDIX III: Reprocessed images review 
BATCH REVIEW OF IMAGES 
Study Batch 1 Batch 2 Batch 3 Batch 4 Batch 5 Batch 6 
Ventilation  1 – 33 34- 67 68- 101 102 – 135 136-169 170-200 
Perfusion  34 - 67 68- 101 102 - 135 136 – 169 170-200 1 – 33 
Ventilation with 
perfusion 
68 - 101 102 - 135  136-169 170-200 1-33 34- 67 
CXR 102-135 136-169 170-200 1-33 34-67 68-101 
Perfusion with 
CXR 
136-169 170-200 1-33 34-67 68-101 102-135 
Ventilation with 
CXR 






3.4 APPENDIX IV: Lung Segments 
PICTORAL REPRESENTATION OF LUNG SEGMENTS 
 
Source: Adapted and modified from Bajc M, Neilly JB, Miniati M, Schuemichen C, Meignan M, Jonson 
B. EANM guidelines for ventilation/perfusion scintigraphy: Part 1. Pulmonary imaging with 











3.5 APPENDIX V: Data sheets 
DATA SHEET 1 
Study: Perfusion  
 Ventilation   
Date _______ 
Study serial number ______ 
Folder number _______ 
 
Technical quality: Adequate 
    Inadequate  
 Adequate – normal sinogram, intravenous injection, no clumping of MAA, counts    
 Inadequate; why? _____________________     
 
Is it normal? Yes  No  
 If No, what is the abnormality?  
  Inhomogeneous  
  Central deposition of activity 
  Big heart impression 
  Abnormal V or Q gradient 
  Others (specify) _______________ 
Number of defects ______ 
Number Character Location size Shape Pleural 
based 
Segmental 
       
       
       
       
Location – lung segments = (right lung-R1 – R10; left lung- L1 –L10); right lobes – RUL, RML, RLL; left 
lobes- LUL, LLL (see appendix 1) 
Size – 25%, 50% or 75% sub segmental, segmental, lobar, whole lung  
Shape – wedge shaped, crescentic, non-wedge shaped; character – reduced V or Q/ absent V or Q 




DATA SHEET 2 
Ventilation Perfusion images 
Date _______ 
Study serial number ______ 
Folder number _______ 
 
Is there a perfusion defect? Yes   No 
















            
            
            
            
Associated ventilation defect = Yes /No 
Size of the associated ventilation defect= Same/Bigger/Smaller 
 
Are there other ventilation defects?  Yes   No 
Number character Location size shape Pleural 
based 
Segmental  
       
       
       


















Study ID  
Folder no  
Date   
Technical quality Readable  Unreadable 
Inspiration    
Rotation    
Penetration    
Features of PE  Location  
 Yes No RUZ RMZ RLZ LUZ LMZ LLZ 
Pulmonary oligaemia         
Central vessel enlargement with 
abrupt tapering 
        
Peripheral consolidation abutting 
the pleura 
        
Atelectasis         
Small pleural effusion         
Elevated hemidiaphragm         
Right ventricular enlargement         
Increased lung field density/opacity  Location  
 Yes No RUZ RMZ RLZ LUZ LMZ LLZ 
Lobar consolidation         
Broncho pneumonic          
Interstitial changes         
Nodular infiltration         
Fibrosis          
Tumour          
Other lung field abnormalities  Location  
 Yes No Right  Left  
Hyperinflation     
Perihilar nodes      
Airway compression     
Pneumothorax     
Pulmonary oedema     
Massive pleural effusion     
 Yes  No   Yes  No 
Tracheal deviation   Soft tissue changes   
Mediastinal deviation   Spine abnormality   






DATA SHEET 4 
Study:  Perfusion + Chest X-ray     
 Ventilation + Chest X-ray 
Date _______ 
Study serial number ______ 
Folder number _______ 
 


























          
          
          
          
Associated lung field opacity = yes/no 
Size of the associated lung opacity = same/ bigger/ smaller  
 


















Diagnosis       
Number Location  Size Cause b 
    





DATA SHEET 5 
Patient’s data 
Date ___________ 
Study serial number ___________ 
Folder number ______________ 
Age _______ 
Gender _____ 
Co morbidity (ies) _________ 
 
 
